MGRX — Mangoceuticals Balance Sheet
0.000.00%
- $7.74m
- $7.57m
- $0.46m
Annual balance sheet for Mangoceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.023 | 0.683 | 0.739 | 0.059 | 1.49 |
| Net Total Receivables | — | — | — | — | 0.02 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.023 | 0.695 | 0.818 | 0.076 | 1.55 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0 | 0.292 | 0.215 | 0.062 | 0.31 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.023 | 1 | 1.05 | 15.4 | 16.1 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.039 | 0.261 | 0.211 | 1.43 | 0.891 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.039 | 0.389 | 0.276 | 1.42 | 0.889 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.017 | 0.614 | 0.775 | 13.9 | 15.2 |
| Total Liabilities & Shareholders' Equity | 0.023 | 1 | 1.05 | 15.4 | 16.1 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |